ANGPTL1 and Miyoshi myopathy: As suggested by Ronchetti et al., lnc‐ANGPTL1‐3 was significantly upregulated in MM patients,25 which was associated with poor prognosis and activated c‐Maf expression via sponging miR‐30a‐3p, thereby inhibiting the effects of proteasome inhibitors.48